NOT-CA-04-031: Addendum - Specialized Programs of Research Excellence (SPOREs) in Human Cancer for the Year 2004 (PAR-03-158)

Department of Health
and Human Services (HHS)

NIH... Turning Discovery Into Health^®

Addendum - Specialized Programs of Research Excellence (SPOREs) in Human Cancer for the Year 2004 (PAR-03-158)

Notice Number: NOT-CA-04-031

Key Dates
Release Date: September 23, 2004

Issued by
National Cancer Institute (NCI), (http://www.nci.nih.gov/)

This addendum is to inform potential applicants of a correction regarding the budget cap under the section, "Mechanism of Support," for PAR-03-158 entitled "SPECIALIZED PROGRAMS OF RESEARCH EXCELLENCE (SPOREs) IN HUMAN CANCER FOR THE YEAR 2004." The published PAR incorrectly mentioned exclusion of 3rd party direct cost and facilities and administrative cost from the budget cap of $1.75 million. The correction is as follows:

In complying with the direct cost cap of $1.75 million, the facilities and administrative costs related to subcontracts to other institutions or organizations do not apply toward the direct cost cap. However, these consortium facilities and administrative costs must be included in the total cost which, overall, may not exceed the $2.75 million cap. The corrected second paragraph for the section "Mechanism of Support" is shown below.

Mechanism of Support

NCI policy for SPORE grants establishes the following limits to the requested budgets: new or competing renewal P50 SPORE applications may request a maximum annual direct cost of up to $1.75 million and maximum annual total cost of $2.75 million. The facilities and administrative costs related to subcontracts to other institutions or organizations are included in the total cost cap of $2.75 million, but not in the direct cost cap of $1.75 million. Applications can exceed these caps in subsequent years as a result of standard cost-of-living increases or special supplements approved by NCI. A SPORE grant application may be submitted for up to 5 years of funding.

Inquiries

Inquiries regarding this notice may be directed to:

Rashmi Gopal Srivastava, Ph.D. (for Breast Cancer SPOREs)
Jane Fountain, Ph.D. (for Gynecological Cancer SPOREs)
Office of Centers, Training, and Resources
Organ Systems Branch
National Cancer Institute
6116 Executive Boulevard, Suite 7013, MSC 8347
Bethesda, MD 20892-8347 (for express/courier service)
Rockville, MD 20852 (for U.S. Postal Service)
Telephone: (301) 496-8528
Fax: (301) 402-5319

Weekly TOC for this Announcement
NIH Funding Opportunities and Notices